A single-arm, phase II study of envafolimab combined with chemoradiotherapy and recombinant human endostatin in high-risk locally advanced nasopharyngeal carcinoma

被引：0
|
作者：
Zhang, H. [1 ]
Zhang, X. [2 ]
Wang, F. [2 ]
Sui, J. [2 ]
Wang, Y. [2 ]
机构：
[1] Chongqing Univ, Sch Med, Chongqing, Peoples R China
[2] Chongqing Univ, Canc Hosp, Radiat Oncol Ctr, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.482
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
459TiP
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nivolumab combined with chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): A multicenter, single-arm, phase II clinical trial
    Xu, Cheng
    Shen, Liangfang
    Yang, Kun-Yu
    Hu, Desheng
    Chen, Xiaozhong
    Lin, Shaojun
    Jin, Feng
    Zhou, Qin
    Peng, Gang
    Huang, Jing
    Wu, Yuan
    Tao, Changjuan
    Li, Ji-Bin
    Zhao, Hongyun
    Hong, Shu-Bin
    Huang, Hui-Ling
    Li, Wen-Fei
    Zhou, Guan-Qun
    Sun, Ying
    Ma, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 138 - 138
  • [2] Efficacy of recombinant human endostatin combined with chemoradiotherapy for locally advanced nasophartyngeal carcinoma
    Li, Yuanyuan
    Jin, Fang
    Wu, Weili
    Long, Jinghua
    Luo, Xiulin
    Gong, Xiuyun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Lv, Jiahua
    Li, Tao
    Deng, Xiaorong
    Li, Fang
    Song, Yanqiong
    Li, Churong
    Wang, Junchao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Recombinant human endostatin combined with definitive chemoradiotherapy for patients with locally advanced esophageal carcinoma
    Ge, Xiaoling
    Wang, Yuandong
    Wen, Wei
    Zhu, Hongcheng
    Ye, Hongxun
    Yang, Xi
    Chen, Jiayan
    Cao, Yuandong
    Zhang, Sheng
    Mu, Qingxia
    Cheng, Hongyan
    Ma, Jianxin
    Dai, Shenbin
    Guo, Qing
    Yang, Baixia
    Cai, Jing
    Yang, Min
    Sun, Xinchen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20137 - 20144
  • [5] Envafolimab plus chemoradiotherapy for locally advanced nasopharyngeal carcinoma (NPC), a prospective, singlearmed phase II trial
    Wang, X.
    Han, F.
    Huang, Y.
    Xu, C.
    Mao, Y.
    Lin, L.
    Chen, Y.
    Chen, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S581 - S581
  • [6] Tislelizumab combined with induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A prospective, single-arm, phase II trial
    Li, M.
    Qu, S.
    Lan, G.
    Shi, M.
    Wang, Y.
    Ban, M.
    Weng, J.
    Wei, J.
    Huang, W.
    Gui, Z.
    Mao, X.
    Huang, X.
    Xie, S.
    Wang, H.
    Huang, B.
    Qin, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S632 - S632
  • [7] Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason Chia-Hsien
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [8] Neoadjuvant tislelizumab combined with CAPOX for MSS/pMMR high-risk locally advanced colon cancer: A single-arm, exploratory phase II clinical study
    Lin, M.
    Xia, Z.
    Chen, H.
    Liao, C.
    Huang, W.
    Li, H.
    Huang, J.
    Liu, M.
    Song, R.
    Xie, Y.
    Zhang, X.
    Liang, J.
    Gan, J.
    Guo, Y.
    Zhang, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S21 - S21
  • [9] Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features
    Jin, P.
    Gao, Y.
    Fu, Z.
    Yang, W.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E454 - E454
  • [10] Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
    Ou, Dan
    Cai, Rong
    Qi, Wei-Xiang
    Cui, Can
    Cao, Lu
    Wang, Shu-Bei
    Li, Huan
    Ma, Tao
    Miao, Ying
    Xu, Cheng
    Cai, Gang
    Cao, Wei-Guo
    Gao, Yun-Sheng
    Chen, Jia-Yi
    Xu, Hao-Ping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
12345